The treatment of mantle cell lymphoma (MCL) is evolving. Join us for this innovative live satellite symposium that will feature a review and discussion of key clinical trial data with renowned clinical experts providing their perspectives focused specifically on BTK inhibitor-based therapy. In addition, enjoy a little friendly competition during the symposium as you will be challenged with a series of patient cases and polling questions presented as part of a Team Trivia style quiz game. Additionally, attendees will have ample ability to directly interact with the expert panel and contribute to the content of the program via submission of questions. Critical insights on the similarities and differences among multiple different BTK inhibitors will help prepare attendees to safely and effectively use these agents in their practice. Discussion and case topics will include: 1) Recent updates to the treatment landscape in MCL; 2) Mechanisms, pharmacokinetics, pharmacodynamics, and efficacy of currently available BTK inhibitors; 3) The evolving role of BTK inhibitors in treatment-naïve MCL; 4) The management of relapsed/refractory disease considering resistance or intolerance to prior therapy; 5) Practical discussions with multiple expert perspectives on the implementation of new data and current clinical challenges.